BRITNEY IANNANTUONO: Open Payments
NPI 1558810648 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $269 |
| CVRx, Inc. | 1 | $189 |
| Abbott Laboratories | 1 | $108 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| PFIZER INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Barostim Neo System, Kerendia, Adempas, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, AMVUTTRA, VYNDAQEL, Wegovy, JARDIANCE.
Industry payments across OH — which companies pay providers there.
